These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 4374230

  • 41. Collaboration between distinct subpopulations of T cells in in vitro generation of effector cells capable of growth prevention of syngeneic SV40-induced sarcoma in mice.
    Glaser M.
    Cell Immunol; 1979 Nov; 48(1):71-8. PubMed ID: 228868
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Cytological characteristics of mouse lymphatic nodes in viral cancerogenesis].
    Hudym-Levkovych KA, Surkina II, Sherban SD, Kovbasiuk SA.
    Mikrobiol Zh; 1976 Nov; 38(6):722-6. PubMed ID: 1004285
    [No Abstract] [Full Text] [Related]

  • 49. Tumor infiltrating lymphocytes.
    Klein E, Becker S, Svedmyr E, Jondal M, Vánky F.
    Ann N Y Acad Sci; 1976 Nov; 276():207-16. PubMed ID: 1071962
    [No Abstract] [Full Text] [Related]

  • 50. Effect of normal serum and antithymocyte serum on Friend disease in mice.
    Larson CL, Ushijima RN, Baker RE, Baker MB, Gillespie CA.
    J Natl Cancer Inst; 1972 May; 48(5):1403-7. PubMed ID: 4337911
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Kinetics of inflammation and sarcoma cell development in primary Moloney sarcoma-virus-induced tumors.
    Becker S, Haskill S.
    Int J Cancer; 1981 Feb 15; 27(2):229-34. PubMed ID: 7287218
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Immunogenicity of soluble murine histocompatibility antigens.
    Sagi S, Turianskyj FH, Gyenes L.
    Immunol Commun; 1974 Feb 15; 3(1):85-94. PubMed ID: 4823533
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. An analysis of variables affecting the measurement of tumor immunity in vitro with 125I-iododeoxyuridine-labelled target cells. Studies of immunity to primary Moloney sarcomas.
    Seeger RC, Rayner SA, Owen JJ.
    Int J Cancer; 1974 May 15; 13(5):697-713. PubMed ID: 4367342
    [No Abstract] [Full Text] [Related]

  • 59. Development and persistence of cytolytic T lymphocytes in regressing or progressing Moloney sarcomas.
    Gillespie GY, Russell SW.
    Int J Cancer; 1978 Jan 15; 21(1):94-99. PubMed ID: 304846
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.